There are various measurement methods used to communicate the value creation to investors. At the corporate level the measures normally used can be both internal (accounting data) or external (stock market data). Accounting measures, such as EPS, ROI, ROE and ROCE have the advantage that they are simple and easy to calculate. However, they refer to the short-term, while the creation of value depends on long-term cash flows. On the other hand, measures that are based on stock market evaluations, such as MVA, MBR and TSR, present problems involving stock price fluctuations, which can depend on factors outside the control of management as well as those management can act on (specific information, for example acquisitions or mergers). This article seeks to show the principal measures of the corporate value normally adopted. In particular, it will present the results of an analysis on the corporations' market value and the principal value measures used to communicate the value creation to investors in the pharmaceutical sector.
|Keywords:||Corporate Value, Value Measures, Value Communication, Pharmaceutical Industry|
Faculty of Economics, Dipartimento di Ricerche Aziendali, Faculty of Economics, University of Pavia, Pavia, Italy
There are currently no reviews of this product.Write a Review